Concepedia
Statistics
Publications
8
Citations
300
H-Index
Active since
2018
Affiliations
Erasmus MC Cancer Institute(Current)
Erasmus MC
KU Leuven
Heidelberg University
Erasmus University Rotterdam
Wies Vallentgoed is an author at Erasmus MC Cancer Institute specializing in oncology, molecular biology, and medicine.
Publications per year
2018–2025
The selective autophagy receptors Optineurin and p62 are both required for zebrafish host resistance to mycobacterial infection
Rui Zhang, Mónica Varela, Wies Vallentgoed et al. · PLoS Pathogens · 2019 · 79 citations · Full text
Life Sciences, Infectious Diseases, Molecular Biology +17
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
C. Mircea S. Tesileanu, Wies Vallentgoed, Marc Sanson et al. · Acta Neuropathologica · 2021 · 56 citations · Full text
Medicine, Genetics, Oncology +17
The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
Tathiane M. Malta, Thaís S. Sabedot, Natalia S. Morosini et al. · Cancer Research · 2023 · 55 citations · Full text
Medicine, Molecular Biology, Oncology +17
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data
Levi van Hijfte, Marjolein Geurts, Wies Vallentgoed et al. · iScience · 2022 · 40 citations · Full text
Life Sciences, Bioinformatics, Molecular Biology +17
Finding the Right Way to Target EGFR in Glioblastomas; Lessons from Lung Adenocarcinomas
Ya Gao, Wies Vallentgoed, Pim J. French · Cancers · 2018 · 24 citations · Full text
1–5 of 8